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ABSTRACT 
Chronic kidney disease (CKD) is a rapidly growing global health problem, affecting 5-10% 
of the general population, and individuals with CKD have a substantially increased risk of 
morbi-mortality. Early detection and treatment can delay or prevent onset many of the 
adverse outcomes of CKD. However, due to insufficient knowledge about factors that drive 
CKD incidence, renal function decline and complications of CKD, our capacity to implement 
effective preventive strategies is limited. This thesis explores associations of dietary/lifestyle 
risk factors with kidney dysfunction and diet-related outcomes. 
Study I investigated the associations between dietary fiber and systemic inflammation, kidney 
function and mortality risk. We found that higher dietary fiber intake was associated with better 
renal function and lower inflammation. Higher fiber intake was also associated with better 
survival, especially in individuals with manifest CKD.  
 
Study II investigated the implications of circulating phosphate levels, reflecting in part 
dietary intake of phosphorus, on the risk of adverse clinical outcomes in patients with 
manifest cardiovascular disease (CVD). We found that both higher and lower phosphate 
levels associated with increased risk of adverse outcomes during the index CVD 
hospitalization and within one-year post-discharge. Risk associations were already present in 
the normal-range serum phosphate levels.   
Study III addressed the pro-inflammatory load of the diet as a potential cause of kidney 
dysfunction. By combining putatively pro-inflammatory and anti-inflammatory effects of 
nutrients, vitamins, and trace elements, a dietary pattern was generated that correlated with 
both renal function and systemic inflammatory biomarkers. We found that pro-inflammatory 
diet associated with lower kidney function and that the association between this dietary 
pattern and renal function was substantially mediated by systemic inflammation. 
Study IV addressed the association between dietary acid load and mortality in the 
community. Both excessive dietary alkalinity and acidity, showed weak associations with 
mortality in a U-shaped fashion. An acid-base balanced diet was associated with the 
minimum mortality rate. However, the magnitude of mortality reduction was modest, 
suggesting that dietary modifications of the alkalinity of the diet may not be very relevant 
overall to reduce mortality risk.  
Study V investigated whether the association between obesity and incident CKD affected by 
genetic confounding and/or explained by obesity-associated diabetes among twins. We 
observed that controlling for shared risk factors between twin pairs minimally affected the 
association between body mass index (BMI) and CKD. In twins with discordant BMI, heavier 
siblings had a higher adjusted incidence rate of CKD than leaner ones. After adjusting for 
diabetes development, the strength of the association was reduced (suggesting effect 
mediation), but remained statistically and clinically significant. We concluded that a higher 
BMI, irrespective of genetic confounding or incident diabetes, was associated with CKD. 
  
  
LIST OF SCIENTIFIC PAPERS 
This thesis is based on the following papers. They are referred to in the text by their Roman 
numerals (I-V): 
I. Xu H,  Huang X,  Risérus U,  Krishnamurthy VM,  Cederholm T,  Arnlöv J,  
Lindholm B,  Sjögren P,  Carrero JJ. Dietary fiber, kidney function, inflammation, 
and mortality risk. Clinical journal of the American Society of Nephrology 2014 
9;12 2104-10 
 
II. Xu H,  Evans M,  Gasparini A,  Szummer K,  Spaak J,  Ärnlöv J,  Lindholm B,  
Jernberg T,  Carrero JJ. Outcomes associated to serum phosphate levels in patients 
with suspected acute coronary syndrome. International journal of cardiology 2017 
245; 20-26 
 
III. Xu H,  Sjögren P,  Ärnlöv J,  Banerjee T,  Cederholm T,  Risérus U,  Lindholm B,  
Lind L,  Carrero JJ. A pro-inflammatory diet is associated with systemic 
inflammation and reduced kidney function in elderly adults. Journal of nutrition 
2015 145;4 729-35 
 
IV. Xu H,  Åkesson A,  Orsini N,  Hakansson N,  Wolk A,  Carrero JJ. Modest U-Shaped 
Association between Dietary Acid Load and Risk of All-Cause and Cardiovascular 
Mortality in Adults. Journal of nutrition 2016 146;8 1580-5 
 
V. Xu H, Kuja-Halkola R, Chen X, Magnusson P, Svensson P, Carrero JJ. Impact of 
genetic confounding and incident diabetes in the association between body mass 
index and chronic kidney disease: a population-based swedish twin study. In 
submission. 
 
 
 
 
 
 
 i 
 
RELATED PAPERS 
Not included in this thesis 
1. Xu H,  Huang X,  Arnlöv J,  Cederholm T,  Stenvinkel P,  Lindholm B,  Risérus U,  Carrero JJ. Clinical 
correlates of insulin sensitivity and its association with mortality among men with CKD stages 3 and 4. 
Clinical journal of the american society of nephrology 2014 9;4 690-7 
2. Xu H,  Jia T,  Huang X,  Risérus U,  Cederholm T,  Arnlöv J,  Sjögren P,  Lindholm B,  Carrero JJ. 
Dietary acid load, insulin sensitivity and risk of type 2 diabetes in community-dwelling older men. 
Diabetologia 2014 57;8 1561-8 
3. Xu H,  Huang X,  Risérus U,  Cederholm T,  Lindholm B,  Ärnlöv J,  Carrero JJ. Urinary albumin 
excretion, blood pressure changes and hypertension incidence in the community: effect modification by 
kidney function. Nephrology, dialysis, transplantation : official publication of the European Dialysis and 
Transplant Association - European Renal Association 2014 29;8 1538-45 
4. Jia T,  Huang X,  Qureshi AR,  Xu H,  Ärnlöv J,  Lindholm B,  Cederholm T,  Stenvinkel P,  Risérus U,  
Carrero JJ. Validation of insulin sensitivity surrogate indices and prediction of clinical outcomes in 
individuals with and without impaired renal function. Kidney international 2014 86;2 383-91 
5. Xu H,  Huang X,  Risérus U,  Cederholm T,  Sjögren P,  Lindholm B,  Ärnlöv J,  Carrero JJ. Albuminuria, 
renal dysfunction and circadian blood pressure rhythm in older men: a population-based longitudinal cohort 
study. Clinical kidney journal 2015 8;5 560-6 
6. Xu H,  Cabezas-Rodriguez I,  Qureshi AR,  Heimburger O,  Barany P,  Snaedal S,  Anderstam B,  Helin 
ACB,  Carrero JJ,  Stenvinkel P,  Lindholm B. Increased levels of modified advanced oxidation protein 
products are associated with central and peripheral blood pressure in peritoneal dialysis patients. Peritoneal 
dialysis international 2015 35;4 460-70 
7. Xu H,  Watanabe M,  Qureshi AR,  Heimburger O,  Barany P,  Anderstam B,  Eriksson M,  Stenvinkel 
P,  Lindholm B. Oxidative dna damage and mortality in hemodialysis and peritoneal dialysis patients. 
Peritoneal dialysis international 2015 35;2 206-15 
8. Xu H,  Carrero JJ,  Lindholm B. Reducing insulin resistance in patients undergoing peritoneal dialysis 
through the use of icodextrin-based solutions. Nephrology, dialysis, transplantation : official publication of 
the European Dialysis and Transplant Association - European Renal Association 2015 30;11 1783-5 
9. Xu H,  Wolk A,  Carrero JJ. Parental History of Cardiovascular Disease and Risk of ESRD in Women. 
American journal of kidney diseases : the official journal of the National Kidney Foundation 2015 66;4 
726-8 
10. Xiong Z,  Xu H,  Huang X,  Ärnlöv J,  Qureshi AR,  Cederholm T,  Sjögren P,  Lindholm B,  Risérus 
U,  Carrero JJ. Nonesterified fatty acids and cardiovascular mortality in elderly men with CKD. Clinical 
journal of the American Society of Nephrology : 2015 10;4 584-91 
 ii 
 
11. Rossi M,  Johnson DW,  Xu H,  Carrero JJ,  Pascoe E,  French C,  Campbell KL. Dietary protein-fiber 
ratio associates with circulating levels of indoxyl sulfate and p-cresyl sulfate in chronic kidney disease 
patients. Nutrition, metabolism, and cardiovascular diseases: 2015 25;9 860-5 
12. Jia T,  Risérus U,  Xu H,  Lindholm B,  Ärnlöv J,  Sjögren P,  Cederholm T,  Larsson TE,  Ikizler TA,  
Carrero JJ. Kidney function, β-cell function and glucose tolerance in older men.The Journal of clinical 
endocrinology and metabolism 2015 100;2 587-93 
13. Xu H,  Xiong Z,  Ärnlöv J,  Qureshi AR,  Cederholm T,  Sjögren P,  Lindholm B,  Risérus U,  Carrero 
JJ. Circulating Alpha-Tocopherol and Insulin Sensitivity Among Older Men With Chronic Kidney Disease. 
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney 
Foundation 2016 26;3 177-82 
14. Xu H,  Rossi M,  Campbell KL,  Sencion GL,  Ärnlöv J,  Cederholm T,  Sjögren P,  Risérus U,  Lindholm 
B,  Carrero JJ. Excess protein intake relative to fiber and cardiovascular events in elderly men with chronic 
kidney disease. Nutrition, metabolism, and cardiovascular diseases 2016 26;7 597-602 
15. Xu H,  Ärnlöv J,  Sandhagen B,  Risérus U,  Lindholm B,  Lind L,  Carrero JJ. Lipophilic index, kidney 
function, and kidney function decline. Nutrition, metabolism, and cardiovascular diseases 2016 26;12 1096-
1103 
16. Xu H,  Brusselaers N,  Lindholm B,  Zoccali C,  Carrero JJ. Thyroid Function Test Derangements and 
Mortality in Dialysis Patients: A Systematic Review and Meta-analysis. American journal of kidney 
diseases : the official journal of the National Kidney Foundation 2016 68;6 923-932 
17. Xu H,  Gasparini A,  Ishigami J,  Mzayen K,  Su G,  Barany P,  Ärnlöv J,  Lindholm B,  Elinder CG,  
Matsushita K,  Carrero JJ. eGFR and the Risk of Community-Acquired Infections. Clinical journal of the 
American Society of Nephrology 2017 12;9 1399-1408 
18. Xu H,  Carrero JJ. Insulin resistance in chronic kidney disease. Nephrology (Carlton, Vic.) 2017 22 
Suppl 4; 31-34 
19. Su G,  Xu H,  Marrone G,  Lindholm B,  Wen Z,  Liu X,  Carrero JJ,  Lundborg CS. Chronic kidney 
disease is associated with poorer in-hospital outcomes in patients hospitalized with infections: Electronic 
record analysis from China. Scientific reports 2017 7;1 11530- 
20. Klatte DCF, Gasparini A, Xu H,  de Deco P,  Trevisan M,  Johansson ALV,  Wettermark B,  Ärnlöv J,  
Janmaat CJ,  Lindholm B,  Dekker FW,  Coresh J,  Grams ME,  Carrero JJ. Association Between Proton 
Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease. Gastroenterology 2017 153;3 702-
710 
21. Chauveau P,  Aparicio M,  Bellizzi V,  Campbell K,  Xu H,  Johansson L,  Kolko A,  Molina P,  Sezer 
S,  Wanner C,  Ter Wee PM,  Teta D,  Fouque D,  Carrero JJ,  Mediterranean diet as the diet of choice for 
patients with chronic kidney disease. European Renal Nutrition (ERN) Working Group of the European 
Renal Association–European Dialysis Transplant Association (ERA-EDTA). Nephrology, dialysis, 
transplantation : official publication of the European Dialysis and Transplant Association - European Renal 
Association 2018 1;33(5):725-735 
 iii 
 
22. Xu H, Faxén J, Szummer K, Trevisan M, Kovesdy CP, Jernberg T, Carrero JJ. Dyskalemias and adverse 
events associated with discharge potassium in acute myocardial infarction.  American heart journal 2018    
22; 205:53-62 
23. Su G, Xu H,  Riggi E, He Z, Lu L, Lindholm B, Marrone G, Wen Z, Liu X, Johnson DW, Carrero JJ, 
Lundborg CS. Association of Kidney Function with Infections by Multidrug-Resistant Organisms: An 
Electronic Medical Record Analysis. Scientific reports  2018 6;8 (1):13372- 
24. Su G,  Xu Y,  Xu X,  Xu H,  Lu L,  Marrone G,  Lindholm B,  Wen Z,  Liu X,  Johnson DW,  Carrero 
JJ,  Lundborg CS. Association between reduced renal function and cardiovascular mortality in patients 
hospitalized with infection: A multi-center cohort study. European journal of internal medicine 2018 Epub 
ahead of print. 
25. Su G, Liu Z, Qin X, Xu H,  Liu X, Wen Z, Lindholm B, Carrero JJ, Johnson DW, Brusselaers N, 
Lundborg CS. Vitamin D deficiency and treatment versus risk of infection in end-stage renal disease 
patients under dialysis: A systematic review and meta-analysis. Nephrology, dialysis, transplantation : 
official publication of the European Dialysis and Transplant Association - European Renal Association 
2018 Epub ahead of print. 
26. Carrero JJ,  Trevisan M,  Sood MM,  Bárány P,  Xu H,  Evans M,  Friberg L,  Szummer K. Incident 
Atrial Fibrillation and the Risk of Stroke in Adults with Chronic Kidney Disease: The Stockholm 
CREAtinine Measurements (SCREAM) Project. Clinical journal of the American Society of Nephrology 
2018 Epub ahead of print.  
27. Ishigami J, Trevisan M, Xu H,  Coresh J, Matsushita K, Carrero JJ. Low eGFR as a leading attributable 
factor of hospital acquired infections following major surgery. American journal of kidney diseases : the 
official journal of the National Kidney Foundation 2018 Epub ahead of print.  
28. Xu H, Hashem A, Witasp A, Mencke R, Goldsmith D, Barany P, Bruchfeld A, Wernerson A, Carrero 
JJ, Olauson H, Fibroblast growth factor 23 is associated with fractional excretion of sodium in patients with 
chronic kidney disease.  Nephrology, dialysis, transplantation : official publication of the European Dialysis 
and Transplant Association - European Renal Association 2018 (In press). 
 iv 
 
CONTENTS 
1. BACKGROUND .......................................................................................................................................... 1 
1.1 INTRODUCTION .................................................................................................................................. 1 
1.2 QUANTITY AND QUALITY OF SINGLE NUTRIENTS ............................................................................. 1 
1.2.1 Dietary fiber................................................................................................................................. 2 
1.2.2 Phosphorus .................................................................................................................................. 3 
1.3 DIETARY PATTERNS ............................................................................................................................ 4 
1.3.1 Healthy dietary patterns ............................................................................................................. 4 
1.3.2 Unhealthy dietary patterns ......................................................................................................... 5 
1.4 LIFE STYLE FACTORS AND CKD ........................................................................................................... 5 
1.4.1 BMI ............................................................................................................................................... 6 
1.4.2 Other lifestyle risk factors ........................................................................................................... 6 
1.5 DIETARY ASSESSMENT, STUDY DESIGNS: GENERAL CONSIDERATIONS ........................................... 6 
1.5.1 Dietary Assessment ..................................................................................................................... 7 
1.5.2 Study designs ............................................................................................................................... 9 
2. AIMS ........................................................................................................................................................ 10 
3. MATERIALS AND METHODS ................................................................................................................... 11 
3.1 PARTICIPANTS .................................................................................................................................. 11 
3.1.1 ULSAM ....................................................................................................................................... 11 
3.1.2 PIVUS ......................................................................................................................................... 11 
3.1.3 SMC ............................................................................................................................................ 11 
3.1.4 COSM ......................................................................................................................................... 11 
3.1.5 SWEDEHEART ............................................................................................................................ 11 
3.1.6 SCREAM ..................................................................................................................................... 12 
3.1.7 The Swedish Twin Registry ....................................................................................................... 12 
3.2 STUDY DESIGNS ................................................................................................................................ 13 
3.2.1 Study I ........................................................................................................................................ 13 
3.2.2 Study II ....................................................................................................................................... 13 
3.2.3 Study III ...................................................................................................................................... 13 
3.2.4 Study IV ...................................................................................................................................... 14 
3.2.5 Study V ....................................................................................................................................... 14 
 v 
 
3.3 METHODS ......................................................................................................................................... 14 
3.3.1 Dietary assessments .................................................................................................................. 14 
3.3.2 Laboratory analyses .................................................................................................................. 14 
3.3.3 Follow up ................................................................................................................................... 15 
3.3.4 Statistical analyses .................................................................................................................... 15 
4. MAIN RESULTS AND DISCUSSION .......................................................................................................... 16 
4.1 FIBER, KIDNEY FUNCTION, INFLAMMATION AND MORTALITY ...................................................... 16 
4.2 SERUM PHOSPHATE AND ADVERSE OUTCOMES ............................................................................ 17 
4.3 INFLAMMATORY DIET AND KIDNEY FUNCTION .............................................................................. 19 
4.4 DIETARY ACID LOAD AND MORTALITY ............................................................................................ 20 
4.5 BMI AND CKD ................................................................................................................................... 21 
4.6 STUDY CONSIDERATIONS ................................................................................................................. 22 
4.6.1 Strengths of the studies ............................................................................................................ 22 
4.6.2 Limitations of the studies ......................................................................................................... 22 
5. CONCLUSIONS ........................................................................................................................................ 24 
6. FUTURE PERSPECTIVES ........................................................................................................................... 25 
7. ACKNOWLEDGEMENTS .......................................................................................................................... 26 
8. REFERENCES ............................................................................................................................................ 28 
 
 
 
 
 
 
 
 
 
 
 vi 
 
LIST OF ABBREVIATIONS 
ACS Acute Coronary Syndrome 
ADII Adapted Dietary Inflammatory Index 
BMI Body Mass Index 
CKD Chronic Kidney Disease 
COSM Cohort of Swedish Men  
CRP C-Reactive Protein 
CVD Cardiovascular disease  
ESRD End-Stage Renal Disease 
eGFR Estimated glomerular filtration Rate 
PIVUS Prospective Investigation of the Vasculature in Uppsala 
Seniors 
SALT Screening Across Lifespan Twin  study 
SCREAM Stockholm CREAtinine Measurements project 
SMC Swedish Mammography Cohort 
STR Swedish Twin Registry  
ULSAM Uppsala Longitudinal Study of Adult Men  
 1 
 
1. BACKGROUND 
 
1.1 INTRODUCTION  
 
Chronic kidney disease (CKD), defined as albuminuria and/or decreased glomerular filtration rate 
(GFR) [1], is a rapidly growing global health problem, affecting about 10% of the community, 
with a much higher prevalence among the older and those with comorbid diabetes or 
cardiovascular disease (CVD) [2]. Renal failure or end-stage renal disease (ESRD) represents the 
end of disease progression, requiring renal replacement therapy in the form of dialysis or renal 
transplantation. CKD patients, even at early disease stage, have a substantially increased risk of 
morbidity due to CVD, malnutrition, inflammation, mental disorders, and other complications, 
which collectively leads to high hospitalization rates and excess mortality risk [3, 4]. Adverse 
outcomes of CKD can be prevented by early detection. However, due to insufficient knowledge 
about factors that drive renal function decline, CKD and ESRD incidence, our capacity to 
implement preventive strategies is limited.  
A few management options are able to retard CKD progression and reduced CKD-related 
complications, some of them including dietary modifications [5]. Diet restriction has been a 
cornerstone management strategies in patients with CKD for more than one century, such as the 
use of low protein diets for secondary CKD prevention [6, 7]. However, many dietary aspects 
remained unexplored in their potential to alleviate CKD outcomes. It is true that current guidelines 
for CKD management recommend a number of dietary changes [5, 8], but these derived from 
observations in population screenings and fail to address important components of the modern 
diet. Finally, it is acknowledged that adherence to a healthy lifestyle is followed by a reduced risk 
of worse outcomes in the general population [9], but few studies have evaluated selected lifestyle 
factors in CKD [10].  
 
1.2 QUANTITY AND QUALITY OF SINGLE NUTRIENTS  
 
The role of diet in health and disease is far more complex than the isolated effects of single nutrient 
combinations, and public health guidelines for primary prevention of chronic diseases are 
progressively shifting from a single-nutrient/food item focus to recommendations regarding whole 
foods and patterns of dietary quality. However, the dietary management of CKD and ESRD 
patients has focused on limiting the quantity within single nutrient of substances such as protein, 
phosphorus, potassium, or sodium that can accelerate kidney damage and/or accumulate in uremia 
reaching toxic levels [5, 8]. Less or no attention has been devoted to the quality and the diversity 
of the diet, and with these restrictions in mind, it is probably not unexpected that the quality of the 
diet in patients with CKD is not considered as “healthy” [7, 11-14].  
 
For instance, although much research addresses the safety and effectiveness of low protein diets, 
little focus has been given to protein sources. Recent cohort studies intriguingly suggest that 
whereas high intake of animal protein associates with increased progression of CKD, substitution 
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for plant protein reduces considerable this risk [15], and associates with reduced mortality rates in 
individuals with CKD [16].  
 
Further, current guidelines fail to make any recommendation regarding the intake and the quality 
of many other nutrients. This is the case for dietary fat, with observational studies associating 
saturated fatty acids (SFAs) intake with CKD progression and incident albuminuria [17-20] and 
even interventional trials and meta-analyses indicating beneficial effects of polyunsaturated fat 
intake in retarding kidney function decline [21-24]. One recent cohort study showed that a high 
lipophilic index, which was utilized as a reflection of dietary fat quality, was independently 
associated with the odds CKD progression [25].  
 
The quality of carbohydrate intake has likely a major influence on risk of many chronic diseases. 
Consumption of high glycemic load grains, potatoes, or added sugars has been related to the 
development of non-communicable diseases including cardiovascular disease, diabetes and 
obesity; On the other hand, whole fruits, legumes, leafy vegetables, and kernel grains appear as 
protective for these outcomes [26]. For CKD, a number of studies showed that the consumption of 
artificially sweetened sodas associates with albuminuria incidence and rapid GFR decline [27, 28]. 
However, with few exceptions this has not translated into interventional studies restricting 
sugar/sweetener intake in CKD patients. A clinical trial in CKD patients reported that a diet with 
low amounts of fructose was effective in reducing a number of inflammatory biomarkers and blood 
pressure compared a control diet with habitual fructose intake [29]. Dietary sugar may increase 
uric acid levels, promote hyperglycemia, hypertension and obesity,  increasing the risk of diabetes 
mellitus, which is one of the most common causes of CKD [30].  
 
1.2.1 Dietary fiber  
A high dietary fiber intake is recommended as a part of healthy diet in many clinical guidelines 
for the prevention of several chronic diseases. There are numerous meta-analyses showing an 
inverse association between dietary fiber and CVD event or CVD mortality [31], as well as 
glycemic control and diabetes management [32], metabolic syndrome [33] and cancer risk 
reduction [34].  However, because of hyperkalemia fear, fruits and vegetables (the main source of 
fiber), patients with CKD are often advised under current dietary fiber recommendations [5, 8]. 
Studies on the benefits or harms of fiber intake on CKD are, so far, limited. Interestingly, a meta-
analysis from 14 clinical trials in patients without CKD showed that dietary fiber fortification 
significantly lowered serum urea and plasma creatinine concentrations in a very short follow up 
period [35]. Dietary fiber correlated with reduced risk of CVD events and/or mortality in adults 
with reduced renal function [31, 36]. The possible benefits of increased fiber intake are many, but 
to date have not been investigated. For instance, outside the renal arena, a study from the 
Prevención con Dieta Mediterránea (PREDIMED) trial, showed a strong negative correlation 
between dietary fiber and subsequent risk of death, which was mainly attributed to a lower risk of 
CVD-deaths [37]. The Third National Health and Nutritional Examination Survey (NHANES III) 
cohort reported a similar inverse correlation between dietary fiber and inflammation and death, 
which was stronger in individuals with CKD compared those without [38].  Similarly, Study I 
showed dietary fiber intake positively associated with renal function and negatively associated 
with inflammation. Higher fiber intake was also associated with lower mortality risk in the 
community [39].  
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The cardio-renal protective effect of dietary fiber is plausibly attributed to health benefits of fiber 
on intermediate risk factors for CVD including blood pressure reduction, decreased waist 
circumference, body weight loss, lowering fasting blood sugar and high-density-lipoprotein-
cholesterol [40]. In addition, dietary fiber may delay gastric emptying, bind bile acid, compete 
with dietary protein as substrates for fermentation by the gut flora [41]. In this sense, a recent trial 
in CKD patients showed that increased fiber intake was similarly effective to pharmacological 
treatments in the management of constipation, a common complication of CKD [42]. Dietary fiber 
is also accompanied by increased vitamin intake and antioxidant intake, that can lead to lower 
endogenous production of acid, and reduced production of uremic toxins such as p-cresyl sulfate 
and indoxyl sulfate, two considered risk factors for accelerated CKD progression [43]. The 
favorable effect of fiber-rich diets on systemic inflammation is also suggested by a previous 
epidemiologic study [44].  
After our study was published [39], other reports have confirmed and expanded clinical 
associations of increased fiber intake in persons with CKD: In population-based cohort, higher 
fiber intake associated with a decreased risk of CKD [45] and in another study lower dietary fiber 
associated with faster CKD progression in CKD patients [46]. In addition, we could also show that 
a diet high in protein and poor in fiber increases uremic toxin production [47] and associates with 
the incidence of CVD events in patients with CKD [48]. High protein and low fiber also lowers 
the acid load. High dietary acid load was significantly correlated to the risk of ESRD among 
individuals with albuminuria from NHANES III [49].  
 
1.2.2 Phosphorus  
Dietary phosphorus comes from organic and inorganic sources. Organic phosphorus is bound to 
dietary protein, and therefore variations in the amount of protein intake will primarily affect 
phosphorus intake. However, the intestinal absorption of dietary phosphorus is higher if coming from 
animal sources (40-60% absorption) than from vegetable sources (10-30% absorption). On the other 
hand, inorganic phosphorus, which is often added to processed foods for conservation and 
enhancement of taste, is almost entirely absorbed in the intestine and represents an important hidden 
source of phosphorus in the diet. The estimation of phosphorus intake from dietary recalls is 
challenging, since inorganic phosphorus content is neither reported in food labels nor accounted for 
in food composition software.  
 
Said this, serum phosphate concentration is affected by many processes that regulate phosphorus 
metabolism, including excretion of phosphorus by renal tubules, and electrolyte exchanges in bone 
metabolism. An increase in the serum phosphate concentration over the normal range is frequently 
a feature at a late stage of CKD, mainly when eGFR<45 ml/min, a state of kidney disease in which 
compensatory mechanisms are no longer sufficient to maintain phosphorous balance [50]. On 
maintenance dialysis, hyperphosphatemia risks are particularly heightened, with a prevalence as high 
as 50% [51]. 
 
Current recommendations for phosphorus intake in CKD recommend to reduce intake to 800-1000 
mg/day, adding phosphate binders if found appropriate [52]. These recommendations are rooted 
on the strong adverse event prediction of serum phosphate levels in CKD patients. However, in 
truth, there are very few studies to support the effect of dietary restriction on CKD outcomes and 
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results are mixed [53-59]. Although many studies have explored the risks of hyperphosphatemia 
in CKD, this may not be well-known outside nephrology. Study II demonstrated that even in 
patients with normal renal function, variations in serum phosphate within the normal range were 
associated with in-hospital and after discharge mortality in acute myocardial infarction patients 
[60].  
 
1.3 DIETARY PATTERNS 
 
Because of the inherent associations of macro- and micronutrients within foods and patterns of 
diet, it is likely that the quality of the diet and the cumulative exposure to a specific dietary pattern 
may be more influential on CKD than excess or deficiency of one specific macro- or micronutrient 
[61]. The role of the food and regulating homeostasis is far more complicated than delivering a 
single mix of nutrients, Although, there is some clinical trial evidence supporting the benefit of a 
holistic diet modification versus single nutrient approaches [62, 63], most of information on 
healthy-eating patterns derive from observational studies. These recent studies mainly emerge 
from large population-based studies where serum creatinine is available and estimated GFR can 
be calculated, bringing new light into primary prevention strategies for CKD.  
 
1.3.1 Healthy dietary patterns  
The scientific community has developed a wide array of methods identify dietary patterns and 
assess their impact on health. The most common approach has been the creation of scores of 
different foods that indicate the degree of adherence to the healthy dietary patterns and then use 
the score to examine its association with clinical outcomes. Such as the case of the Healthy Eating 
Index (HEI), which has been associated with lower risk of albuminuria in participants with diabetes 
from the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial 
(ONTARGET) [64]. Substitution analyses from HEI score attributed in part this effect to fruit and 
vegetable intake; when participants consumed >14 servings/week of fruit and vegetables, their 
associated ESRD risk lowered by 2-5%, and their mortality risk was 5-10% lower [65].  
The characteristics of Mediterranean Diet Score (MDS) generally considers a high intake of olive 
oil, fresh fruits, vegetables, whole grains, legumes and nuts, a moderate intake of fish and other 
sea food, a low-to-moderate intake of cheese and yogurt, a low intake of sweets and red meat, 
finally accompanied by a moderate intake of red wine. Adherence to MDS has been correlated 
with better renal  function in cross-section study [66] and with a slight improvement of renal 
function after one year of intervention in high risk of elderly patients with coronary heart disease 
[67]. Following a MDS was also associated with lower risk of incident CKD and slower kidney 
function decline [68], predicting the risk of mortality among persons with CKD [69].  
A low salt diet, represented by adherence to Dietary Approaches to Stop Hypertension (DASH) 
patterns, correlated with reduced CKD incidence in two population-based cohorts [70, 71] and in 
selected high-risk populations that may benefit from reduced salt intake, such as individuals with 
dysglycemia, dyslipidemia or hypertension [72]. Low-moderate salt consumption also appears to 
potentiate the anti-proteinuric effect of angiotensin converting enzyme inhibitor (ACEI), 
angiotensin receptor blocker (ARB) and vitamin D receptors [73, 74]. Said these, DASH-style 
dietary interventions have yet been conducted to discern its benefits in patients with CKD. 
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The NIH-AARP Diet and Health Study showed collectively that these dietary quality scores 
(Alternate HEI, HEI, MDS, and DASH) were associated with 15-30% decreased risk of the 
composite outcome of dialysis and renal death [75]. The common characteristics of these scores 
of healthy eating were summarized in recent meta-analyses and include generally increased intake 
of fruits and vegetables, but reduced intake of red meat, refined sugar and sodium, features that 
were consistently associated with decreased mortality risk in people with CKD [76]. Nonetheless, 
the association between healthy dietary patterns and risk of ESRD did not attain statistical 
significance [76]. The consequences of healthy eating in dialysis populations have been scarcely 
studied, with to date only one recent multinational cohort study providing some light in this issue. 
The results so far are disappointing, as no association was observed between adherence to MDS 
or DASH diets and the risk of (cardiovascular) mortality [77]. It may be that dialysis patients are 
too sick, and dietary modifications may not be enough. We could also consider that dialysis 
patients are a selected group of survivors of CKD progression. In any case, we need dietary 
intervention studies to find this out. Currently, interventional evidence on the effects of dietary 
changes beyond protein intake in adults with CKD are very preliminary, affected by low samples 
size and short duration, not having examined mortality as an endpoint [78-80].   
 
1.3.2 Unhealthy dietary patterns 
Western diets are characterized by a high intake of red meat, processed foods, butter, high-fat dairy 
products, sweets, and a low intake of fruits, vegetables, highly refined grains and sugars. 
Adherence to a Western diet has been related to increased risk of albuminuria and more faster 
kidney function decline [81].   
The components of the diet affect the acid-base balance of the human body [82, 83]. Net alkaline 
foods generally include fruits and vegetables, and net acidified foods include meat, cheese, grains 
and eggs [84]. While the so-called Western diets are collectively acidifying diets, vegetarian diets 
are considered to be alkalizing [85, 86]. Excess of acidifying over alkalinizing nutrients may in 
theory lead to endogenous acid production and potentially metabolic acidosis [87]. Dietary acid 
load can estimated by validated algorithms that precisely consider this acid- or base-forming 
capacity of nutrients [88, 89]. Study IV studied these estimations of acid load in a large community 
screening, and results suggested that both dietary acid and alkali excess may entail a similarly 
increased mortality risk, especially due to CVD-related causes [90].  
Diet most likely plays a crucial role in the regulation of systemic inflammation [91]. Nutrients 
considered anti-inflammatory, such as n-3 polyunsaturated fatty acids (PUFA), fiber, or vitamins 
[92-94],  related to lower risk of albuminuria, and less rapid kidney function decline [39, 95, 96]. 
On the other hand, nutrients with pro-inflammatory properties, such as SFAs, or sugars [97, 98] 
associated with declined renal function [99, 100]. The overall balance in the intakes of pro- and 
anti-inflammatory food items/nutrients may impact on inflammatory status. Using validated scores 
[101, 102] of the pro-inflammatory net effect of diets, Study III convincingly showed that such 
unhealthy pattern correlates with both renal function and systemic inflammatory biomarkers [103].  
 
1.4 LIFE STYLE FACTORS AND CKD 
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Unhealthy diet, obesity [104], physical inactivity, smoking, alcohol consuming, drug abuse [105], 
sleep loss or shift work, stress  [106], and overuse of  technologies such as mobile telephone and 
computer [107] are modern examples of unhealthy lifestyles. It is recognized that following a healthy 
lifestyle is correlated with better outcomes in the general population [108]. Unhealthy lifestyles are 
leading causes of morbidity including obesity, diabetes, CVD, musculoskeletal disease, dementia, 
cancer and mortality worldwide [105, 108]. Smoking, poor dietary quality, low physical activity, 
and excess alcohol intake account for over 30% of deaths in the U.S. [105].  
 
1.4.1 BMI 
While some population-based studies report an association between obesity and incident CKD, 
evidence somewhat conflicting [109-113]. Several explanations for these discrepancies have been 
suggested, including selection bias, insufficient control of confounders, or problems with 
normalization to body surface area in estimated glomerular filtration rate equations [109, 112]. 
Since both obesity [114] and CKD [115] are partly inherited, genetic factors shared by obesity and 
CKD could as well explain this association. Despite a number of metabolic factors have been 
thought as contributors to obesity-induced CKD, the underlying signaling mechanisms are not well 
understood [116]; It could be that obesity leads to CKD by prompting the development of other 
intermediate diseases such as diabetes [117]. In Study V, we observed, however, that neither 
genetic confounding nor incident diabetes abrogated the association between a high-body mass 
index (BMI) and CKD risk, providing strong evidence in support of a direct effect.  
 
1.4.2 Other lifestyle risk factors 
Scarce number of studies have evaluated lifestyle habits in CKD populations. Perhaps not 
unexpectedly, they generally report adverse outcomes associated with smoking and physical 
inactivity [10, 118]. Counter-intuitively though, studies that test the correlation between alcohol 
consumption with the risk of CKD observed mostly inverse associations, and conclude that there 
is no strong ground for discouraging light/moderate alcohol consumption at least in terms of 
kidney effects [119, 120]. A study from the NHANES III showed that following a healthy lifestyle 
(BMI, dietary quality, smoking status, and physical activity) was correlated with lower risk of 
death in adults with non-dialysis CKD [121].  Another study from the Chronic Renal Insufficiency 
Cohort (CRIC) showed that normal weight (BMI≤25kg/m2), regular physical activity, and non-
smoking were correlated with lower risk of adverse outcomes such as CKD progression, 
atherosclerotic events and all-cause mortality in individuals with CKD [122].  
 
Lifestyle and behaviors such as smoking and physical activity are intrinsically linked to dietary 
habits. Patient interventions in this sense prove difficult given the multidimensional aspects of 
lifestyle to target. The benefits of manipulating multiple components of diet and lifestyle have not 
been fully assessed.  
 
 
1.5 DIETARY ASSESSMENT, STUDY DESIGNS: GENERAL CONSIDERATIONS 
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1.5.1 Dietary Assessment  
A number of different methods can assess food intake. Many studies rely on questionnaires called 
food frequency questionnaires (FFQ). Another way to assess dietary intake is by asking people to 
recall all the foods (and amounts) they ate over the past 24 hours, which is called 24h dietary recall. 
Other method for keeping track of food intake is a food diary or food record. People write down 
and sometime weigh all the food they eat for a week or perhaps even longer. Food diaries have the 
advantage that they can be quite accurate if done well. The next step is to convert the information 
from the food questionnaires and food records into nutrient intake, which is done using so-called 
food composition tables that contain information on the nutrient content of a great variety of foods 
consumed in a certain region or country. The nutrients include fat, carbohydrate (fiber and sugar), 
protein, and many vitamins and minerals. Combining the information on how often people eat 
certain foods with information on the nutrient content of these foods allows researchers to estimate 
the nutrient intake [123]. One limitation of food composition tables is that they are incomplete: 
many food products are not listed, which forces nutrition researchers to select an alternative food 
product to calculate nutrient intake. Further, the amount of added nutrients in the form of additives 
or preservatives (such as sodium, potassium or phosphorus) in processed foods is not quantified. 
Nowadays many people use diet and nutrition apps to monitor their food and caloric intake [124]. 
It is important to note that the described approach to estimate nutrient intake forms the basis of 
nearly all observational studies.  Advantages and disadvantages of dietary assessment methods are 
listed in Table 1. 
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Table 1 Dietary assessment methods in epidemiological studies [124] 
 Methods Collection date Advantage Disadvantage 
Food 
frequency 
questionnaire 
Subjective data 
collection with 
predefined, self- or 
interviewer-
administered 
questions 
Habitual intake 
estimates over 
a long period 
Assessment is 
simple, cost- and 
time-effective; good 
for large cohorts 
Specific to study groups and 
research objectives; a closed-
ended questionnaire; low 
accuracy (recall bias); requires 
accurate assessment of 
developed questionnaires 
24-Hour 
dietary recall 
Subjective data 
collection using 
open-ended 
templates and 
assisted by an 
interviewer 
Habitual intake 
information 
over the 
preceding 24 
hours 
Provides detailed 
intake information; 
relatively small 
respondent burden 
  
Recall bias; trained interviewer 
required; Interviewer bias; 
expensive and time-consuming; 
multiple days required to assess 
usual intake; possible changes to 
diet if repeated measures 
Dietary 
record or 
Dietary diary  
Subjective data 
collection using 
open-ended, self-
administered 
questionnaires 
Actual intake 
information 
throughout a 
specific period; 
seven days or 
more 
Provides detailed 
intake data; no 
interviewer 
required;  
no recall bias 
Relatively large respondent 
burden (literacy and high 
motivation required, possible 
under-reporting); expensive and 
time-consuming; multiple days 
required to assess usual intake; 
possible changes to diet if 
repeated measures 
Modern 
techniques 
Complementing food 
frequency 
questionnaire 
Pictures of 
foods, 
graphics, etc. 
Collects more 
accurate data 
Difficult to convert images into 
quantitative food intake data;  
Measurement errors 
 Complementing 24-
Hour dietary recall 
Software, 
internet, etc. 
Standardized data 
collection (reducing 
interviewer bias);  
cost- and time-
saving; improves 
feasibility 
Self-report bias 
 Complementing 
dietary records 
Software, 
internet, ipads, 
mobile phone, 
application, 
etc. 
Standardized, real-
time data collection; 
cost- and time-
saving; improves 
feasibility 
Self-report bias; requires 
participant training on how to 
use the technology 
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1.5.2 Study designs  
In this thesis, we have utilized a variety of study designs, each of them with strengths and 
limitations. Table 2 provides a quick overview of the various research designs and their strengths 
and weaknesses in nutrition research.  
 
Table 2  Study design in nutritional epidemiology [125]. 
Class of study Type of study Methods Timeline Strength Limitation 
Experimental Intervention Randomized 
control trial  
Varies, can be 
short 
Specific factors  Expensive 
Observational Ecological Population based 
rather than 
individual 
Existing data Large number 
of people and 
risk-modifying 
factors  
Cannot explore 
individuals 
Observational Cross-section Compares existing 
data for two 
conditions 
Exposure and 
outcome are 
assessed at the 
same time 
Many 
databases are 
available  
Inability to assign 
temporal relation 
between exposure 
and outcome, prone 
to confounding 
Observational Case-control Group with 
disease are collect 
for the case, 
disease free 
subjects for the 
control 
Retrospective Enable the 
study of rare 
disease 
Prone to selection 
bias and 
confounding 
Observational Cohort-
prospective 
Assess dietary 
habits of a large 
group at the 
beginning, look at 
the rate at which 
they develop 
disease 
Follow up over  
length of time, 
years 
Most powerful 
observational 
study design in 
epidemiology 
Depends on 
accuracy of food 
intake reporting 
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2. AIMS 
 
The overall aim of this thesis was to explore dietary/lifestyle CKD risk factors and implications 
of kidney dysfunction on dietary-related outcomes. 
The specific aims of each study: 
To investigate the association between selected single nutrients and CKD outcomes. Studies 
included: 
 Dietary fiber intake and its association with kidney function, inflammation, and 
mortality risk (Study I). 
 Serum phosphate levels, as a reflection of dietary phosphorus, and its association with 
the risk of adverse clinical outcomes in patients with manifest CVD (Study II).  
To investigate the association between selected dietary patterns and CKD outcomes. Studies 
included: 
 The pro-inflammatory load of the diet as a cause of kidney dysfunction (Study III).  
 Dietary acid load and the risk of mortality (Study IV). 
To investigate the association between obesity and incident CKD. Study included: 
 The possible role of genetic confounding and/or obesity-associated diabetes for the 
association between obesity and incident CKD (Study V). 
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3. MATERIALS AND METHODS 
 
3.1 PARTICIPANTS 
This thesis was developed with data obtained from seven observational cohorts:  
 
3.1.1 ULSAM 
The Uppsala Longitudinal Study of Adult Men (ULSAM) is a community survey of all available 
men born in 1920-24 in Uppsala County, initiated in 1970-1974, when all 50-year-old men living 
in Uppsala, Sweden, were invited to participate in a health survey. Participants returned for re-
examinations at 60, 70, 77 and 82 years of age (http://www2.pubcare.uu.se/ULSAM/). The thesis 
utilizes the third ULSAM examination cycle, when all participants were 70-71 years old (n= 1221, 
examinations performed during 1991-95) and when 7-day estimated dietary records were collected 
for the first time. There is information on follow-up characterization of co-morbidity and death.  
 
3.1.2 PIVUS 
The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study share a similar 
design with ULSAM. During 2001-2004, PIVUS invited all 70-year-old individuals (men and 
women) living in Uppsala, Sweden, to participate in a similar survey with common protocols to 
ULSAM (http://www.medsci.uu.se/pivus/). PIVUS initially recruited 1016 individuals (507 men 
and 509 women). Long-term follow up of more than 10 years is available.  
 
3.1.3 SMC  
The Swedish Mammography Cohort (SMC) is a population cohort of all women in the Uppsala 
and Västmanland, Sweden (http://ki.se/en/imm/unit-of-nutritional-epidemiology). All women 
born in 1914-1948 participated in a mammography screening program were asked to answer a 
questionnaire about diet and lifestyle in 1987-1990. In late autumn 1997, all women still alive and 
living in the study area received an expanded questionnaire including 350 diet and lifestyle-related 
items. A total of 39,227 women (70% response rate) returned this second questionnaire. This thesis 
was based on the second survey.   
 
3.1.4 COSM  
The Swedish Cohort of Men (COSM) is a population cohort of men born in 1918-1952 who at the 
time of the questionnaire's establishment in 1997 were living in the Västmanland and Örebro. 
48,850 (49% response rate) men answered a questionnaire about diet and lifestyle. The 
questionnaires used and information collected are the same as in the SMC 
(http://ki.se/en/imm/unit-of-nutritional-epidemiology).  
 
3.1.5 SWEDEHEART  
The nationwide Swedish Web-System for Enhancement and Development of Evidence-Based care 
in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) registry 
[126] is a National Quality Register that contains patients who are admitted to CCUs or other 
specialized facilities because of symptoms suggestive of acute coronary syndrome (ACS)  in whole 
Sweden. The registry prospectively collects information on patient demographics, cardiovascular 
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risk factors, medical histories, and in-hospital treatments such as coronary revascularization 
procedures, hospital outcomes, discharge medications, and diagnoses. Included until 2015 are 
more than 800.000 incident cases.  
 
3.1.6 SCREAM  
The Stockholm CREAtinine Measurements (SCREAM) project is a healthcare data register of all 
Stockholm citizens accessing healthcare and having a creatinine test taken (about 1.3 million 
individuals) during 2006-2011 [127]. Given the commonness of creatinine testing, SCREAM 
captures a large proportion of the complete population census, making it valid for public health 
research, estimation of disease burden and projections. We performed a linkage between the 
national SWEDEHEART and regional SCREAM, identifying approximately 28.000 Stockholm 
residents with ACS with complete laboratory data during follow up.  
 
3.1.7 The Swedish Twin Registry 
The Swedish Twin Registry (STR) is a Swedish population-based cohort initiated in late 1950s; 
obtains information on twin births occurring in Sweden from National Board of Health and 
Welfare; contains more than 194,000 twins and more than 75,000 pairs today [128]. Twins born 
before 1958 were contacted for the first time interview during the Screening Across Lifespan Twin 
(SALT) study from STR, with the purpose of screening all twins in Sweden for common complex 
diseases, including about 44,825 twins. Questionnaires that included questions about illness and 
health, medication use, occupation, education and life style factors were conducted during 1998-
2002 [129].  
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3.2 STUDY DESIGNS 
Because of specific exclusion criteria in each study and at times missing values of study exposure 
or outcomes, the number of individuals and main parameters considered in each of the studies 
vary, being summarized in Table 3.  
 
Table 3. Description for each study 
 
Study Cohort Subjects Exposure Outcome 
I ULSAM 1,110 Dietary fiber Kidney function, 
inflammation, and mortality 
II Linkage between 
SWEDEHEART and  
SCREAM 
2,547 Serum phosphate In-hospital death and events;  
1 year post-discharge CVD 
events and mortality 
III ULSAM and  
PIVUS 
1,942 Pro-inflammatory  
diet pattern 
Inflammation and kidney 
function 
IV COSM and  
SMC 
81,427 Dietary acid load CVD mortality and  
all-cause mortality 
V SALT 29,136 BMI CKD incidence; diabetes 
incidence 
Abbreviation: COSM, Swedish Cohort of Men; PIVUS, Prospective Investigation of the Vasculature in Uppsala Seniors; 
SALT, Screening Across Lifespan Twin study; SCREAM, Stockholm CREAtinine Measurements project;  SMC, Swedish 
Mammography Cohort ; SWEDEHEART, Swedish Web-System for Enhancement and Development of Evidence-Based 
care in Heart Disease Evaluated According to Recommended Therapies registry; ULSAM, Uppsala Longitudinal Study of 
Adult Men. 
 
3.2.1 Study I 
This is an observational cohort study using data from the ULSAM. Exclusion criteria were lack of 
data on 7-day dietary records and/or serum cystatin C (n=116), and extreme values of reported 
energy intake (<765 or >4300 kcal/day; n=5). Study I therefore comprised 1110 participants.  
 
3.2.2 Study II 
This is an observational cohort study linking SWEDEHEART and SCREAM through the personal 
identification number of each citizen. We included all patient undergoing at least one serum 
phosphate measurement within 24-hours before hospital admission and the discharge date. There 
were   2,547 patients (1,743 men and 804 women, mean age 67±14 years) identified and constitute 
the study population.  
3.2.3 Study III 
This is a cross-sectional study including individuals from two community-based cohorts: the 
ULSAM and PIVUS. Exclusion in ULSAM was unavailable data on dietary records, missing 
serum cystatin C or creatinine, and extreme values of reported energy intake (<765 or >4300 
kcal/day), leaving 1,097 ULSAM participants for this analysis. Exclusion in PIVUS was 
unavailable data on dietary records, serum cystatin C or creatinine, and extreme values of energy 
intake, leaving 845 (422 of which women) PIVUS participants for this analysis. Altogether, the 
joint population for study III included 1,942 (22% women) individuals. 
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3.2.4 Study IV 
This is an observational cohort study including individuals from two community-based cohorts: 
the COSM and SMC. We excluded subjects with missing personal identification number, died 
before the start of follow up, those with baseline history of cancer, those with a history/diagnosis 
of CKD, and those with implausible energy intake. A total of 81,427 individuals (36,470 women 
and 44,957 men) were finally included in Study IV.  
3.2.5 Study V 
This is an observational cohort study including self-reported weight and height to estimate BMI 
from the Swedish Twin Registry. We excluded participants with missing information on birth date, 
if his/her twin did not report weight or height, or if information of zygosity was missing. Finally, 
we excluded participants with history of CKD and diabetes. A total 29,136 twins (14,568 twin 
pairs) were eligible for inclusion in Study V, comprising 10,600 opposite-sex fraternal twins, 
10,694 same-sex fraternal twins and 7,842 identical twins.  
 
3.3 METHODS 
 
3.3.1 Dietary assessments 
In ULSAM and PIVUS, dietary nutrients were evaluated by 7-day dietary records using a pre-
coded menu-book, previously designed and validated by the Swedish National Food 
Administration (NFA) [130]. The participants were given oral instructions by a dietitian on how 
to perform the dietary registration. The daily intake of energy and daily intake of macro-and micro-
nutrients were thereafter calculated by use of a computerized program based on food composition 
tables from the Swedish NFA.  
In COSM and SMC, dietary intake was assessed with a 96-item food frequency questionnaire 
(FFQ). Participants reported how often, on average, they had consumed selected foods over the 
previous year by using predefined frequencies of consumption[131].  
The daily intake of macro-and micro-nutrients in the thesis were corrected for total energy intake 
through the regression analysis of the residual method [132].  
 
3.3.2 Laboratory analyses 
In ULSAM and PIVUS, the assays were performed at the Department of Clinical Chemistry, 
University Hospital, Uppsala, with detailed methods specified in the papers of this thesis. In the 
linkage between SWEDEHEART and SCREAM, laboratory measurements were performed 
during the patient’s CCUs admission and by the clinical laboratories providing services to 
Stockholm County Council.   
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3.3.3 Follow up 
Complete follow-up of the cohorts were obtained through record linkages to the Swedish In-Patient 
Register, the Death (National Board of Health and Welfare), Population Register and the Swedish 
Renal Register (SNR) (http://www.medscinet.net/snr/).  
 
3.3.4 Statistical analyses 
All analyses were performed using Stata version 15.0 (StataCorp, College Station, TX) and R 
(https://www.r-project.org).  
For cohort analyses, we used the traditional Cox proportional hazards model in Study I, II, IV 
and V. In addition, we investigated “dose-response” relationships between exposure and outcomes 
using flexible splines curve in Study II, IV and V [133]. Interaction terms in specific strata were 
also tested in Study I, II, IV and V. We also performed Fine-Gray models accounting for death 
due to non-CVD causes as a competing event in Study II. 
Study III used the multiple-mediation analysis [134, 135] to address the pro-inflammatory load 
of the diet as a cause of kidney dysfunction and whether effect of diet on inflammation explained 
this association.  
Study V performed a co-twin control analysis using stratified Cox regression models (clustering 
the twins in pairs) in order to control for shared factors between the twins, such as age, sex, genes 
and environment shared prior to the study. We also considered incident diabetes as a time-
dependent covariate/mediator in the models. The weighted contribution of overweight and obesity 
to the risk of CKD was quantified with the population attributable fraction [136] .  
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4. MAIN RESULTS AND DISCUSSION 
 
4.1 FIBER, KIDNEY FUNCTION, INFLAMMATION AND MORTALITY 
 
In study I, we showed that dietary fiber positively correlated with eGFR regardless of multiple 
confounders (Table 4). The finding is in agreement with several small sample size studies that 
described a relationship between dietary fiber intake, decreased blood urea nitrogen and increased 
fecal nitrogen excretion in CKD patients [137-139]. We also showed that dietary fiber negatively 
correlated (albeit weakly) with inflammation surrogates.   
 
 
Table 4. Association of fiber intake with estimated glomerular filtration rate (mL/min/1.73m2). 
 
  Unadjusted  Adjusted  
 Cut point/limits Difference (95% 
CI) 
P value Difference (95% 
CI) 
P 
value 
Continuous Model 10g/day higher 3.7 (1.6, 5.9) 0.001 2.6 (0.3, 4.9) 0.03 
Multi-category Model      
Quartile 1 ≤14.5 g/day Reference  Reference  
Quartile 2 >14.5-16.8 g/day 1.4(-0.9,3.7) 0.24 1.5 (-1.0,4.0) 0.23 
Quartile 3 >16.8-19.2 g/day 2.3(0.1,4.6) 0.05 1.4 (-1.1,3.9) 0.27 
Quartile 4 > 19.2 g/day 4.2(1.9,6.5) <0.001 2.9 (0.5,5.4) 0.02 
P for trend  0.01  0.08  
Model adjusted for protein intake, age, BMI, smoking, physical activity, education, comorbidities (cardiovascular 
disease, diabetes, hyperlipidemia, and hypertension), and urinary albumin excretion rate. Modified from [39]. 
 
 
 
We observed that lower fiber intake was more strongly associated with mortality in individuals with 
CKD than in those without; this association was independent of calorie and protein intake, lifestyle 
factors, as well as co-morbidities. Our results expanded previous observations from the U.S. [38]. 
However, contrary to our initial hypothesis, we did not observe any correlation between dietary fiber 
and CVD-related mortality. Instead, the association between fiber and survival was mainly explained 
by lower risk of cancer-related mortality. Finally, we observed a significant interaction product term 
between dietary fiber and eGFR in predicting both all-cause and cancer-mortality. Figure 1 showed 
that after stratification, dietary fiber intake was associated with all-cause and cancer related death in 
individuals with CKD. We observed no association in those without CKD.  
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Figure 1.  Hazard ratios and 95% confidence intervals for dietary fiber (per 10g/day higher) with all-cause, CVD and 
cancer related mortality, stratified by the presence/absence of kidney dysfunction in the entire survey. Reprinted 
with permission [39]. 
 
 
4.2 SERUM PHOSPHATE AND ADVERSE OUTCOMES 
 
Study II showed a J-shaped association between serum phosphate levels and the risk of in-hospital 
adverse events and mortality (Figure 2). In patients with higher phosphate concentrations, the risk 
of CVD event was higher but somewhat flattened (Figure 2B). Low phosphate levels probably 
reflect malnutrition, vitamin D deficiency and/or primary hyperparathyroidism, mechanisms that 
may lie behind this association [140].  
One advantage of our analyses with regards to previous studies [141-143] is the use of models that 
allow for non-linear associations, and models that consider the competing risk of death for other 
causes [144]. In summary Study II showed that both higher and lower phosphate levels associated 
with increased risk of adverse outcomes during the index hospitalization and within one- year post-
discharge in patients with suspected ACS. Risk associations were already present in the normal-
range of serum phosphate levels.  
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A)                                                                 B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. A) Odd ratios and 95% confidence intervals for the composite of in-hospital CVD complications or in-
hospital death associated with serum phosphate (mmol/L). B) Hazard ratios and 95% confidence intervals for the 1-
year composite of CVD events and death associated with serum phosphate (mmol/L) in patients discharged alive. 
Reprinted with permission [60]. 
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4.3 INFLAMMATORY DIET AND KIDNEY FUNCTION 
 
Study III combined pro-inflammatory and anti-inflammatory effects of nutrients, vitamins, and 
trace elements, generated a dietary pattern, and correlated it with both renal function and 
inflammation (Table 5). Our study also suggested that the association between this dietary pattern 
and kidney function was partly explained by systemic inflammation. 
 
Table 5. Associations between adapted dietary inflammatory index (ADII) and serum CRP levels, and between CRP 
levels and estimated kidney function, among 1942 elderly adults aged 70-71 years. 
                                        β coefficients (95% CI) 
 Crude p Adjusted Model  p 
      Association between ADII (per SD increase of 3.26) and CRP levels  
CRP, mg/L  0.06 (0.02, 0.11) 0.01 0.06 (0.01, 0.10) 0.01 
      Association between CRP levels (per mg/L1 increase) and eGFR  
eGFR CKD-EPIcys, 
mL/(min.1.73 m2) 
-0.06 (-0.07, -0.04) <0.001 -0.05 (-0.06, -0.04) <0.001 
eGFR CKD-EPI cys+crea,  
mL/(min.1.73 m2)  
-0.04 (-0.05, -0.03) <0.001 -0.04 (-0.04, -0.03) <0.001 
Model adjusted for energy intake, age, sex, BMI, smoking status, physical activity, hypertension, diabetes, lipid-lowering 
medication and cohort (ULSAM or PIVUS). Abbreviations: ADII, adapted dietary inflammatory index; CKD, chronic 
kidney disease; CRP, C-reactive protein; eGFR, estimated glomerular filtration rate.  Reprinted with permission [103]. 
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4.4 DIETARY ACID LOAD AND MORTALITY 
 
Study IV showed a dose-response correlation between acid load and mortality. 
Mortality rates in PRAL extreme values was higher, showing an approximately U-
shaped relationship. High PRAL (increased dietary acidity) and low PRAL (increased 
dietary alkalinity) were associated with all-cause and CVD related death. In general, 
the magnitude of this association was small (Figure 3).  
Previous studies have identified pathways association with PRAL and CVD risk 
perhaps because of the use of statistical analyses that assume relationships to be linear, 
something that not often occurs in biology. We concluded that an acid-base balanced 
diet was associated with the lowest mortality risk, but the magnitude of this mortality 
reduction was modest. 
 
Figure 3. Hazard ratios and 95% confidence intervals for all-cause in A) women and B) men and 
cardiovascular mortality in C) women and D) men associated with PRAL (mEq/day). Reprinted with 
permission [90]. 
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4.5 BMI AND CKD 
 
We observed that controlling for shared risk factors between twin pairs minimally affected the 
association between BMI and CKD (Table 6). This was true for both fraternal and identical 
twins. In twins with discordant BMI, heavier siblings had a higher adjusted incidence rate of 
CKD than leaner ones, particularly when BMI differed >2 kg/m2. Regardless of baseline BMI, 
heavier siblings presented a higher CKD risk than leaner ones, findings altogether that are 
congruent with a direct effect.  
In Table 7, after adjusting for diabetes development, the strength of the association was reduced 
(suggesting effect mediation), but remained clinically and statistically significant. Thus, our 
findings provide strong evidence of a direct effect between a high BMI and subsequent CKD 
risk. Our population attributable fraction analysis showed that a large proportion of CKD cases 
may be prevented if the population maintained a normal BMI. 
We conclude that a higher BMI, irrespective of genetic confounding or incident diabetes, is 
associated with CKD and congruent with a direct effect. 
Table 6. Cohort and Co-twin control analyses: Hazard Ratio of incident CKD during follow up. 
BMI, (per kg/m2 ) Person-Years Cases HR 95% CI 
Incident CKD      
 Cohort analysis (n=29,136) 381,434 1,113 1.13*** 1.11,1.14 
 Co-twin controlled analyses     
  Fraternal Twins  (opposite sex, n=10,600) 138,129 435 1.18*** 1.12,1.26 
  Fraternal Twins (same sex, n=10,694) 140,091 387 1.16*** 1.09,1.22 
  Identical twins (n=7,842) 103,214 291  1.17** 1.06,1.29 
P for interaction    0.18  
HR adjusted for age, sex, comorbidities (CVD, hypertension and cancer history) and life style habits (alcohol abuse, 
attained education and smoking). Multiplicative interaction between zygosity type and BMI. 
 
Table 7. Cohort and Co-twin control analyses: Hazard Ratio of incident CKD adjusted for the occurrence of 
diabetes mellitus during follow up. 
 
BMI, per kg/m2 increase HR 95% CI 
Cohort analyses    
Adjusted model  1.13*** 1.11,1.14  
Further adjustment for incident DM (time-varying covariate ) 1.06*** 1.04,1.08 
Co-twin controlled analyses   
Fraternal Twins  (opposite sex)   
Adjusted model 1.18*** 1.12,1.26 
Further adjustment for incident DM (time-varying covariate ) 1.12** 1.05,1.20 
Fraternal Twins  (same sex)   
Adjusted model 1.16*** 1.09,1.22 
Further adjustment for incident DM (time-varying covariate ) 1.10** 1.04,1.17 
 Identical Twins   
Adjusted model 1.17** 1.06,1.29 
Further adjustment for incident DM (time-varying covariate ) 1.12* 1.01,1.25 
Model adjusted for age, sex, comorbidities (CVD, hypertension and cancer history) and life style habits (alcohol 
abuse, attained education and smoking). p<0.05, **p<0.01, ***p<0.001. 
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4.6 STUDY CONSIDERATIONS 
 
4.6.1 Strengths of the studies  
Strengths of this thesis include the population-based cohort study designs, detailed data on 
food/nutrients/lifestyle, rich information of confounders, and prospective follow up collection via 
register linkage, with virtually no losses to follow-up. In some cohorts, participants had the same 
age, sex and geographical original. In others, the study population contained participants from a 
defined area where all citizens received universal and tax-funded health care. The twin cohort is 
an invaluable study design to control for genetic confounding [145] and to detect the extent to 
which an association between the environment and an outcome variable is due to familial 
confounding.  
 
4.6.2 Limitations of the studies 
 
Selection bias 
The voluntary screening nature of some of the cohorts here presented in this thesis may introduce 
selection bias, as individuals in good health and interested in diet/lifestyle may be more prone to 
participate. Conversely, non-responders may have poorer health and higher co-morbidity burden 
(Study I, III, IV, V). In Study I and II, the inclusion of Swedish Caucasian individuals of 70-71 
years old is a strength in the sense that minimizes the impact of aging in these associations, but it 
also limits the generalizability of our results to be generally applicable to other races or younger 
peoples (Study I, III). Finally, we included patients with hospitals suspected having ACS who 
had an indication for phosphate testing (Study II), so they may not be extrapolated to the general 
ACS population.   
Confounding and reverse causation bias 
Confounding is an inherent characteristic of all observational studies. We have tried to take this 
into account by adjusting for known ones, but not for residual, unmeasured and unknown 
confounding. Further, errors during participants’ completion of food records (recall bias), risks of 
over-reporting in lean people or underreporting in obese ones [124] may introduce further bias.  
The studies in the thesis aimed to understand the effect of diet/lifestyle on CKD outcomes, which 
implies a direction of causation. Assessing causality in observational studies is not possible and 
associations could operate in both directions. This is often referred to as reverse causation bias: 
e.g. that lower fiber intake is not a risk factor but instead a consequence of dietary adaptions in 
CKD (Study I). We attempted several statistical approaches to tackle this in Study III, including 
mediation analysis. In Studies I, IV and V, we performed sensitivity analyses excluding selected 
participants or immediate person time of follow up.  
 
Misclassification Bias 
Regarding exposure 
Not all possible foods are contemplated in the food frequency questionnaires/records, which limits 
our capacity to accurately account for everything eaten. For instance, in some of our cohorts there 
was no information in the intake of food supplements. This unavoidable limitation of dietary 
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assessments can lead to exposure misclassification, something that in this thesis we have assumed 
to be non-differential. We generally lack biomarkers in plasma/serum or urine to validate our diet 
findings and base our assumptions that intake of nutrients lead to modification of plasma/serum 
biomarkers on previous interventional evidence [146].  
In Study V, BMI was self-reported and BMI itself is a rough measure of adiposity (e.g. models 
only body weight, and a muscular person would also appear as obese). Although other more 
reliable measures such as waist circumference or body fat composition would have been preferred, 
this may be a lesser problem in large population-based samples.  
Regarding outcomes 
Many of study outcomes are based on diagnoses in healthcare, which may be affected by detection 
bias if healthcare is not sought. For instance, the outcome in Study V was CKD diagnosis. 
However, given the unique nature of participants (twins), we assumed that diagnosis of chronic 
diseases in a sibling would prompt similar investigations and follow up in the other one. We 
considered one eGFR estimate as our outcome in Study III, which is subjected to measurement 
variability and would not comply with current recommendations to define CKD on the basis of 
two consecutive reduced eGFR measurements. However, on the other hand, imposing two 
consecutive healthcare visits to define this rare outcome may overemphasize sicker individuals 
accessing healthcare more frequently.  
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5. CONCLUSIONS 
 
This thesis reports associations of various dietary and lifestyle factors with the risk of kidney 
disease and other related outcomes. The main conclusions are:  
 
1. A higher dietary fiber intake is associated with better kidney function and lower inflammation 
in community-dwelling men. A high fiber intake is also associated with lower mortality risk, 
especially in individuals with manifest CKD.  
2. In men and women with suspected acute coronary syndrome, both higher and lower phosphate 
levels associate with increased risk of adverse outcomes during the index hospitalization and 
within one year post-discharge. The risk association is however present already within normal-
range serum phosphate values. 
3. A pro-inflammatory dietary pattern correlates with both kidney function and systemic 
inflammatory biomarkers in community-dwelling elderly men and women. In addition, the 
association between this dietary pattern and kidney function is explained by systemic 
inflammation. 
4. Excess diet alkalinity and acidity, both show weak associations with mortality in a U-shape 
fashion in population screenings of men and women. An acid-base balanced diet is associated with 
the lowest mortality, but the magnitude of mortality reduction is modest and dietary modifications 
of diet’s alkalinity may not be very relevant overall to reduce mortality risk.  
5. A higher BMI, irrespective of genetic confounding or incident diabetes, is associated with CKD 
among twins. 
 25 
 
6. FUTURE PERSPECTIVES  
 
Results from this thesis provide pieces of evidence that improve our understanding of the large 
and complex puzzle of the relationships between diet, lifestyle and chronic kidney disease. Overall, 
our results support the premise that healthy dietary/lifestyle modifications may represent relevant 
strategies to improve kidney health and clinical outcomes.  
 
The high incidence of CKD is a major public health concern. While this thesis focused on the 
impact of some selected single nutrients, and dietary pattern and lifestyles, many other factors 
remain poorly studied. I would like to continue exploring these topics and evaluate, for instance, 
aspects of nutrient quality in CKD management. This may involve the effects of plant vs animal 
protein, organic vs inorganic phosphorus, and improved quality of the intake of dietary fat, 
carbohydrates and protein.  
 
Our studies, and previous literature, define CKD on the bases of a reduced estimated GFR. 
Although this is a currently accepted definition, it may lead to an overrepresentation of the effects 
exerted by ageing among the elderly. Many clinicians would consider a low kidney function among 
elderly individuals to be normal for their age. Separating age-related kidney function decline from 
disease-related kidney function decline is at present not easy. Future studies should attempt to 
better separate lifestyle risks factors for CKD in the community (primary prevention) from those 
to retard disease in nephrology-referred patients (secondary prevention).  
 
For life style factors, our findings may have implications for public health programs aiming at 
improving clinical outcomes. The large population-based Swedish twin registry offered a unique 
opportunity to assess the impact of lifestyle on CKD outcomes. An interpretation of our results is 
that a combination of environmental and lifestyle factors are likely responsible for an increased 
CKD risk attributed to obesity, and this information could have direct application into public health 
prevention campaigns. Although genetic factors can predispose to aggravate the consequences of 
an unhealthy lifestyle, environmental factors can substantially modify genetics-related risks. The 
results support the hypothesis that interventions performed to promote weight loss will be effective 
in reducing the risk of CKD. Other lifestyle factors, such as alcohol consumption, smoking and 
physical activity are other factors of interest to study in the future.  
Considering the commonness of CKD in the general population, more studies supporting the role 
that specific dietary patterns may exert on its onset can have an impact on public health policies, 
while establish the ground for dedicated holistic dietary interventions in this population. Efficient 
trial designs, perhaps linked to registries (registry-randomized trial) or to electronic health records 
may increase the trial feasibility and reduce costs. Considering the unique dietary needs of persons 
with CKD, these trials are necessary to inform clinical decisions and patient recommendations. I 
understand that nutritional trials requires a lot of resources and time, as well as many challenges on 
how to ensure dietary compliance or change unhealthy habits. Success probably requires the 
integrated effort of nephrologists, dietitians, physiotherapists, endocrinologists and nurses.  
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